TAS2R4 and cancer: Moreover, the activation of TAS2R targeted by denatonium benzoate, such as TAS2R4, 8, 10, 13, 39, 43, 46, 47 [35,48], negatively impacted cancer cell physiology, motility, and cell proliferation, while the latter was caused by enhanced cell cycle arrest and apoptosis.